What favours the above mentioned markers is that they are determined by automated biochemical (CRP) and immunochemical methods (TNF-α and IL-6) in serum and are applicable to most biochemical and immunochemical analysers due to increasing clinical application in other conditions and could easily be routinely measured for the diagnosis of GDM if future research confirms their clinical value. Here, IL6 is linked to gestational diabetes.